Press release
Human Papillomavirus (HPV) Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight| Merck, GlaxoSmithKline, Roche, Pfizer and Others.
Human Papillomavirus (HPV) is the most common DNA virus that causes infection in the epithelial cells of skin and mucosa in which moist epithelial surfaces (squamous cells) include all areas covered by skin and/or mucosa such as the mouth interior, throat, tongue, tonsils, vagina, cervix, v#lva, p#nis (the urethra - the opening), and anus.Contact of the above-mentioned areas with a virus leads to the transmission of the virus into, allowing it to transfer between epithelial cells. After establishment, sexual contacts, both conventional and oral becomes the means of transferring HPV through direct skin to skin contact. Other possible pathways for the transfer of virus is poorly known.
DelveInsight's "Human Papillomavirus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Human Papillomavirus (HPV), historical and forecasted epidemiology as well as the Human Papillomavirus (HPV) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To know more about the Human Papillomavirus Market Report: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some Key HPV Market Facts:
• The global HPV associated disorders market size was estimated at USD 16.34 billion in 2018.
• According to DelveInsight, every day in the US, about 12,000 people of ages 15-24 are infected with HPV.
• About 79 million Americans are currently infected with HPV and about 14 million people is likely to become newly infected each.
• According to DelveInsight, every year, approximately 19,400 women and 12,100 men are affected by HPV causing cancers.
Scope of Human Papillomavirus Market Report:
• The report covers the descriptive overview of Human Papillomavirus (HPV), explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Human Papillomavirus (HPV) epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Human Papillomavirus (HPV) are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Human Papillomavirus (HPV) market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Human Papillomavirus (HPV) market
Request for Free Sample Report: https://www.delveinsight.com/sample-request/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
HPV can cause cervical and other cancers including cancer of the v#lva, vagina, p#nis, or anus. It can also cause cancer in the back of the throat, including the base of the tongue and tonsils (called oropharyngeal cancer). Cancer often takes years, even decades, to develop after a person gets HPV. The types of HPV that can cause genital warts are not the same as the types of HPV that can cause cancers.
The percentages of cancers caused by oncogenic HPV are as follows:
• Anal cancer - 90%
• Vu#var cancer - 40%
• Vaginal cancer - 40%
• Oropharyngeal cancer - 12%
• Oral cancer - 3%
To know more about the Human Papillomavirus Overview in detail: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the Key Human Papillomavirus Companies:
• Merck & Co.
• GlaxoSmithKline
• F. Hoffmann-La Roche
• Pfizer
• Allergan
• AstraZeneca
• Biocon Ltd.
• Eli Lilly and Company
• And Many Others
Human Papillomavirus Drugs Covered:
• Gardasil
• Ervarix
• And Many Others
To know more about the Human Papillomavirus Therapies and Companies in detail, click here: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents:
1. Key Insights
2. Executive Summary of Human Papillomavirus (HPV)
3. Competitive Intelligence Analysis for Human Papillomavirus (HPV)
4. Human Papillomavirus (HPV): Market Overview at a Glance
5. Human Papillomavirus (HPV): Disease Background and Overview
6. Patient Journey
7. Human Papillomavirus (HPV) Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Human Papillomavirus (HPV) Treatment
11. Marketed Products
12. Emerging Therapies
13. Human Papillomavirus (HPV): Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Human Papillomavirus (HPV)
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Request for Free Sample Report: https://www.delveinsight.com/sample-request/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Human Papillomavirus (HPV) Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight| Merck, GlaxoSmithKline, Roche, Pfizer and Others. here
News-ID: 2690016 • Views: …
More Releases from DelveInsight Business Research
Global Tumor Ablation Market to reach USD 4,595.68 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The global Tumor Ablations (EHR) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases that require continuous monitoring, data management, and coordinated long-term care. This demand has fueled the need for integrated healthcare systems capable of connecting patient information across multiple departments and care settings. To support this trend, governments worldwide are introducing initiatives, funding, mandates, and regulatory frameworks to promote EHR…
Global Spinal Implants Market to reach USD 21,899.24 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing prevalence of spinal disorders, especially among the aging population, has substantially driven the demand for corrective surgical procedures. At the same time, the rise in sports-related and trauma-induced spinal injuries is boosting the need for advanced implantable solutions. Additionally, there is a growing preference for non-fusion and motion-preserving devices that maintain spinal mobility and improve patient outcomes, particularly among younger and more active individuals.…
Global Vascular Stents Market to reach USD 18,277.68 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing global incidence of cancer is boosting the demand for effective treatment options such as tumor ablation. Minimally invasive procedures are becoming more popular due to their shorter recovery periods, reduced risks, and cost-effectiveness compared to conventional surgery. At the same time, technological advancements in tumor ablation devices-such as improvements in radiofrequency, microwave, and cryoablation technologies-have enhanced precision, safety, and effectiveness, making these procedures increasingly…
Global Vascular Grafts Market to reach USD 3,153.39 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The increasing prevalence of cardiovascular disorders, along with risk factors like hypertension, diabetes, and obesity, is fueling the demand for surgical interventions, thereby supporting the growth of the vascular graft market. Moreover, greater awareness and the expansion of cardiovascular screening programs are enabling earlier diagnosis and timely treatment, further driving the need for vascular grafts.
DelveInsight's "Vascular Grafts Market Insights, Competitive Landscape and Market Forecast-2032" report provides…
More Releases for HPV
Human Papillomavirus (HPV) Vaccine: Core Growth Enabler in the Rising Prevalence …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Human Papillomavirus (HPV) Vaccine Industry Market Size Be by 2025?
The market size for the Human Papillomavirus (HPV) vaccine has seen a swift expansion in the past few years. The market is projected to inflate from $5.8 billion in 2024 to $6.57 billion in 2025, marking…
Global Human Papillomavirus (HPV) Vaccine Market Report 2025: Insights, Drivers …
The Global Human Papillomavirus (HPV) Vaccine Market size reached US$ 3,043.19 Million in 2024 and is expected to reach US$ 12,361.15 Million by 2033, growing at a CAGR of 16.9% during the forecast period 2025-2033.
The Human Papillomavirus (HPV) Vaccines Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data…
Rising Prevalence Of HPV-Related Diseases Sparks Surge In Human Papillomavirus ( …
The Human Papillomavirus (HPV) Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Human Papillomavirus (HPV) Vaccine Market Size During the Forecast Period?
The market size for the human papillomavirus (HPV) vaccine has seen swift growth in the past few years. The…
HPV Vaccines Market 2020-2026 - COVID19 Impact On HPV Vaccines Industry | Top Ke …
HPV Vaccines Market Size, Share & Industry Analysis, By Type (Bivalent and Polyvalent), By Disease Indication (HPV Associated Cancer and Genital Warts), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others) and Geography Forecast, 2019-2026.
Get Sample Copy Of Report To Know The Impact of Covid19 on this Industry: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/human-papillomavirus-hpv-vaccines-market-101962
Top Key Players: GSK, Merck.
An Overview of the Impact of COVID-19 on HPV Vaccines Market:
The emergence of COVID-19 has brought…
HPV Testing & PAP Test Market by Test Type (HPV Testing, Follow-up HPV Testing, …
Global HPV Testing & PAP Test Market was valued at USD XX billion in the year 2017. Global HPV Testing & PAP Test market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023.
Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE385
In the Global HPV Testing & PAP Test Market, by region, North America holds the highest market share…
Cytology and HPV Testing Market: Disparate Levels of Awareness among Patients Re …
Over the years, the level of awareness among the global population regarding the various types of cancer has increased tremendously. The significance of early detection and diagnosis is not lost on them, resulting in the increased adoption of screening tests such as cytology and human papillomavirus (HPV) testing.
The global market for cytology and HPV testing is presented with a host of sustained growth opportunities arising mainly from several emerging economies,…
